Performance

SCTX -22.96%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
SCTX	+6.24%	-22.96%*	-22.96%*	—	-58.64%*	-0.07*	0.00%*

Summary

SCTX at a glance

SCTX returned -22.96% since Jul 24, 2026. Its worst drop since then was -58.64%, smaller than 14% of stocks on Redstone, and its Sharpe ratio of -0.07 beats 24% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How SCTX ranks

Dividend Yield Rank *

Current Drawdown

-55.22%

Rolling Volatility

96.31%

Actions

Metrics

Risk Indicators*

Alpha-14.03%

Beta1.22x

Sharpe-0.07

Sortino-0.09

Omega0.99

Calmar-0.39

Martin-0.24

Profile

About SCTX

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD).

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $316M
Listed: Jul 2026
Headquarters: Alameda, CA
Website: scribetx.com

Comparisons

SCTX: Scribe Therapeutics Inc.

SCTX at a glance

How SCTX ranks

Current Drawdown

Rolling Volatility

About SCTX

Related comparisons